Medpace Holdings, Inc.
MEDP
Updated: 23/09/2026, 02:38:45
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
No summaries found.
- Share price
- $630.19
- Market cap
- $17.59B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- August James Troendle
- Employees
- 6,500
- IPO date
- 11/08/2016
- Beta
- 1.149
- Last dividend
- $0.00
- Day range
- $619.62 – $632.60
- 52-week range
- $373.00 – $677.90
- 1-day performance
- 0.96%
- 1-year performance
- 68.95%
- Current drawdown (1Y)
- -7.04%
- CIK
- 0001668397
- CUSIP
- 58506Q109
- ISIN
- US58506Q1094
- Created
- 07/12/2025, 05:12:58
- Last update
- 23/09/2026, 02:38:45
Track Medpace Holdings, Inc. with an AI analyst
See which prediction-market events move MEDP, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Why the Market Dipped But Medpace (MEDP) Gained Today
Zacks Investment Research • STOCK • 09/06/2026, 21:16:05
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
PRNewsWire • STOCK • 08/06/2026, 21:05:00
MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
Business Wire • STOCK • 08/06/2026, 18:48:00
MEDPACE DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
Newsfile Corp • STOCK • 08/06/2026, 16:22:00
Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)
GlobeNewsWire • STOCK • 08/06/2026, 16:00:00
INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile Corp • STOCK • 08/06/2026, 06:40:00
MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
GlobeNewsWire • STOCK • 07/06/2026, 19:55:00
MEDP DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
Newsfile Corp • STOCK • 07/06/2026, 16:17:00
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
Newsfile Corp • STOCK • 07/06/2026, 09:31:00
MEDP DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
Newsfile Corp • STOCK • 06/06/2026, 14:36:00
MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
PRNewsWire • STOCK • 06/06/2026, 13:08:00
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PRNewsWire • STOCK • 05/06/2026, 17:44:00